Day: February 3, 2026

Survey data from Xometry shows A&D organizations are investing in AI-driven solutions, additive manufacturing and workforce upskilling to accelerate programs in 2026 NORTH BETHESDA, Md., Feb. 03, 2026 (GLOBE NEWSWIRE) — As aerospace and defense (A&D) programs accelerate and production demands increase, organizations across the defense industrial base are preparing for a period of rapid growth. To prepare, A&D leaders are investing in new capabilities to support speed, scale, and resilience, according to a new survey commissioned by Xometry – the global AI-powered marketplace connecting buyers and suppliers of custom manufacturing. The survey found that 41% of A&D leaders anticipate significant acceleration in 2026, outpacing expectations across general industry. As programs scale and timelines compress, leaders...

Agreements with leading Israeli defense manufacturers provide long-term revenue visibility and underscore the critical role of sub-tier suppliers in national defense programs NEW YORK and TEL AVIV, Israel, Feb. 03, 2026 (GLOBE NEWSWIRE) — Nukkleus Inc. (NASDAQ: NUKK) (“Nukkleus” or the “Company”), a strategic acquirer and developer of high-potential businesses in the aerospace and defense industry, announced today that B. Rimon Agencies Inc. (“Rimon”), a well-established Israeli defense engineering and manufacturing firm and wholly owned subsidiary of Nukkleus, has secured multi-year contracts supporting Israel’s national missile defense and homeland security architecture. The agreements, signed with several leading Israeli defense original equipment manufacturers (OEMs), provide for Rimon to manufacture critical power and subsystem...

SAN DIEGO, Feb. 03, 2026 (GLOBE NEWSWIRE) — LPL Financial LLC announced today that the financial advisors of Wealth Innovations, LLC have joined LPL Financial’s broker-dealer and Registered Investment Advisor (RIA) platform. They reported serving approximately $200 million in advisory, brokerage and retirement plan assets* and join LPL from Osaic. Based in Richmond, Va., Wealth Innovations is led by industry veteran Jim LaNeave, who brings nearly four decades of leadership and financial planning experience, alongside Marian Crawford, CFP®, and Samuel LaNeave. The team also includes Ashley LaNeave, Jeffery Brallier, Diane Norris and Janyce LaNeave. Together, they serve clients primarily along the Eastern Seaboard, focusing on individuals at or near retirement. Wealth Innovations specializes in comprehensive retirement planning through...

Collaboration reinforces regulatory diligence, nonclinical strategy and clinical trial integrity for novel intranasal concussion therapy Traumatic brain injuries affect more Americans each year than stroke, Alzheimer’s disease, Parkinson’s disease, multiple sclerosis, and ALS combined Sarasota, Fla., Feb. 03, 2026 (GLOBE NEWSWIRE) — Oragenics, Inc. (NYSE American: OGEN) (“the “Company”), a clinical-stage biotechnology company focused on developing intranasal therapeutics for neurological disorders, today announced it has engaged DUCK FLATS Pharma as its U.S. Investigational New Drug (IND) readiness and regulatory execution partner to support FDA-facing preparation and clinical trial design as the Company advances its novel intranasal concussion therapy toward U.S.-based development. The engagement is intended to align the Company’s...

Collaboration with Stellar Innovation and Integration with ICE Mortgage Technology’s Encompass® System, Expands BLINKQC’s Presence PROVIDENCE, R.I., Feb. 03, 2026 (GLOBE NEWSWIRE) — via IBN – Beeline Holdings (NASDAQ: BLNE), a fast-growing digital mortgage platform redefining the path to homeownership, today announced it has entered into an agreement with Stellar Innovations to integrate Beeline’s proprietary BLINKQC quality control solution into the Encompass® loan origination system by ICE Mortgage Technology. The integration is expected to be live within approximately 90 days. Encompass is the most widely used loan origination system in the U.S., licensed by approximately 3,100 lenders and relied upon by banks, credit unions, and mortgage bankers—particularly mid- to large-scale institutions. Upon completion, the integration...

New patent covers IBSRELA® and XPHOZAH® and expires in 2042 WALTHAM, Mass., Feb. 03, 2026 (GLOBE NEWSWIRE) — Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company founded with a mission to discover, develop and commercialize innovative, first-in-class medicines that meet significant unmet medical needs, today announced that the United States Patent and Trademark Office (USPTO) has issued U.S. Patent No. 12,539,299 titled “Oral Formulations of Tenapanor” with an expiration date of November 26, 2042. The patent relates to the formulation of tenapanor and covers the commercial formulations of IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). The patent will be submitted to the Food and Drug Administration for listing in the Approved Drug Products with Therapeutic Equivalence Evaluations (commonly known as the Orange Book) for both...

MANITOWOC, Wis., Feb. 03, 2026 (GLOBE NEWSWIRE) — Orion Energy Systems, Inc. (NASDAQ: OESX) (Orion Lighting), a provider of energy-efficient LED lighting, electric vehicle (EV) charging stations and maintenance services solutions, today announced an installation project of 105 EV charging stations and related infrastructure in the Boston (MA.) Public School (“BPS”) system. The contract is valued at $4 million. Orion’s Voltrek division is installing 105 DC fast charging stations and related infrastructure at the Freeport Bus Yard operated by the Boston Public Schools, one of the company’s largest customers and one of the most prominent school districts in the United States. Like a number of Orion/Voltrek installations for BPS, the new units feature an innovative above-ground mounting method with Jersey barriers. Orion/Voltrek is...

MONTREAL, Feb. 03, 2026 (GLOBE NEWSWIRE) — Osisko Development Corp. (NYSE: ODV, TSXV: ODV) (“Osisko Development” or the “Company“) is pleased to announce that it has completed its previously announced prospectus offering (the “Offering“) of common shares of the Company (the “Common Shares“). The Offering was completed on a “bought deal” basis, pursuant to an underwriting agreement dated January 27, 2026, among the Company and a syndicate of underwriters comprising National Bank Capital Markets, RBC Capital Markets and Cantor, as co-lead underwriters and co-bookrunners, and BMO Capital Markets (collectively, the “Underwriters“). Pursuant to the Offering, the Company issued an aggregate of 40,607,650 Common Shares at a price of US$3.54 per Common Share for aggregate...

Fort Pierce, FL, Feb. 03, 2026 (GLOBE NEWSWIRE) — Caring Brands Inc. (Nasdaq: CABR) today announced the issuance of two new United States patents covering proprietary methods and compositions designed to enhance enzymatic activity in hair follicles, further strengthening the Company’s intellectual property portfolio supporting its Hair Enzyme Booster product. The newly issued patents, granted by the United States Patent and Trademark Office in January 2026, relate to technologies that increase sulfotransferase enzyme activity to improve the efficacy of topical hair loss treatments. These patents expand Caring Brands’ exclusive protection around mechanisms that are central to the Hair Enzyme Booster, which is currently generating revenue through direct sales in the United States and via international licensees. The newly granted...